Carbamic Acid

Carbamic Acid

SCHEMBL15212189

CN(C)CCCN.NC(=O)O

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.48
ALDH1A1 P00352 3/20 0.41
TSHR P16473 2/20 0.41
PAOX Q6QHF9 2/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
CYP1A2 P05177 2/20 0.40
HRH4 Q9H3N8 2/20 0.40
HRH2 P25021 1/20 0.40
GABRR3 A8MPY1 1/20 0.40
GABRP O00591 1/20 0.40
GABRD O14764 1/20 0.40
HDAC3 O15379 1/20 0.40
GABBR2 O75899 1/20 0.40
LMNA P02545 1/20 0.40
THRB P10828 1/20 0.40
GABRA1 P14867 1/20 0.40
GABRB1 P18505 1/20 0.40
GABRG2 P18507 1/20 0.40
GABRR1 P24046 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Urea SCHEMBL2672240 0.92 TDP1 (0.50) TDP1ALDH1A1TSHRPAOXCYP2C9
Bicarbonate SCHEMBL9617899 0.92 TDP1 (0.50) TDP1ALDH1A1TSHRCYP2C9CYP2C19
Oxalic Acid SCHEMBL5863172 0.90 TDP1 (0.48) TDP1ALDH1A1TSHRCYP2C9CYP2C19
Acetic Acid SCHEMBL3260807 0.90 TDP1 (0.48) TDP1ALDH1A1TSHRPAOXCYP2C9
Glycine SCHEMBL149185 0.88 GLRA1 (0.48) TDP1ALDH1A1TSHRCYP2C9CYP2C19
Propionic Acid SCHEMBL27996411 0.86 FFAR3 (0.46) TDP1ALDH1A1TSHRCYP2C9CYP2C19
Glycolic Acid SCHEMBL4565840 0.86 TDP1 (0.45) TDP1ALDH1A1TSHRCYP2C9CYP2C19
Carbamic Acid SCHEMBL5488417 0.84 ACHE (0.39) TDP1ALDH1A1PAOXCYP2C9CYP2C19
Maleic Acid SCHEMBL27863762 0.84 TDP1 (0.43) TDP1ALDH1A1TSHRCYP2C9CYP2C19
Adipic Acid SCHEMBL1006656 0.84 NFKB1 (0.62) ALDH1A1TSHRCYP1A2GABRR3GABRP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015184326-A1 CONJUGATES, PARTICLES, COMPOSITIONS, AND RELATED METHODS CERULEAN PHARMA INC. (US) 2015-12-03 WO disclosed
WO-2015057847-A1 CONJUGATES, PARTICLES, COMPOSITIONS, AND RELATED METHODS CERULEAN PHARMA INC. (US) 2015-04-23 WO disclosed
EP-2817345-A1 CONJUGATES, PARTICLES, COMPOSITIONS, AND RELATED METHODS Cerulean Pharma Inc. (US) 2014-12-31 EP disclosed
US-20140037573-A1 CONJUGATES, PARTICLES, COMPOSITIONS, AND RELATED METHODS CERULEAN PHARMA INC (US) 2014-02-06 US disclosed
WO-2013126564-A1 CONJUGATES, PARTICLES, COMPOSITIONS, AND RELATED METHODS CERULEAN PHARMA INC. (US) 2013-08-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140037573-A1 CONJUGATES, PARTICLES, COMPOSITIONS, AND RELATED METHODS SYNCRIP, EXOSC5, EXOSC9 TDP1 567/4885ALDH1A1 3222/4885TSHR 2594/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.